Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sirolimus therapy to halt the progression of ADPKD.
Perico N, Antiga L, Caroli A, Ruggenenti P, Fasolini G, Cafaro M, Ondei P, Rubis N, Diadei O, Gherardi G, Prandini S, Panozo A, Bravo RF, Carminati S, De Leon FR, Gaspari F, Cortinovis M, Motterlini N, Ene-Iordache B, Remuzzi A, Remuzzi G. Perico N, et al. Among authors: ondei p. J Am Soc Nephrol. 2010 Jun;21(6):1031-40. doi: 10.1681/ASN.2009121302. Epub 2010 May 13. J Am Soc Nephrol. 2010. PMID: 20466742 Free PMC article. Clinical Trial.
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.
Caroli A, Antiga L, Conti S, Sonzogni A, Fasolini G, Ondei P, Perico N, Remuzzi G, Remuzzi A. Caroli A, et al. Among authors: ondei p. Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17. Am J Pathol. 2011. PMID: 21683674 Free PMC article.
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.
Ruggenenti P, Gaspari F, Cannata A, Carrara F, Cella C, Ferrari S, Stucchi N, Prandini S, Ene-Iordache B, Diadei O, Perico N, Ondei P, Pisani A, Buongiorno E, Messa P, Dugo M, Remuzzi G; GFR-ADPKD Study Group. Ruggenenti P, et al. Among authors: ondei p. PLoS One. 2012;7(2):e32533. doi: 10.1371/journal.pone.0032533. Epub 2012 Feb 28. PLoS One. 2012. PMID: 22393413 Free PMC article.
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial.
Ruggenenti P, Podestà MA, Trillini M, Perna A, Peracchi T, Rubis N, Villa D, Martinetti D, Cortinovis M, Ondei P, Condemi CG, Guastoni CM, Meterangelis A, Granata A, Mambelli E, Pasquali S, Genovesi S, Pieruzzi F, Bertoli SV, Del Rosso G, Garozzo M, Rigotti A, Pozzi C, David S, Daidone G, Mingardi G, Mosconi G, Galfré A, Romei Longhena G, Pacitti A, Pani A, Hidalgo Godoy J, Anders HJ, Remuzzi G; ARCADIA Study Organization. Ruggenenti P, et al. Among authors: ondei p. Clin J Am Soc Nephrol. 2021 Apr 7;16(4):575-587. doi: 10.2215/CJN.12940820. Epub 2021 Mar 29. Clin J Am Soc Nephrol. 2021. PMID: 33782036 Free PMC article. Clinical Trial.
New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.
Bellasi A, Cozzolino M, Malberti F, Cancarini G, Esposito C, Guastoni CM, Ondei P, Pontoriero G, Teatini U, Vezzoli G, Pasquali M, Messa P, Locatelli F. Bellasi A, et al. Among authors: ondei p. J Nephrol. 2020 Apr;33(2):211-221. doi: 10.1007/s40620-019-00677-0. Epub 2019 Dec 18. J Nephrol. 2020. PMID: 31853791 Free PMC article.
Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
Genovesi S, Rebora P, Gallieni M, Stella A, Badiali F, Conte F, Pasquali S, Bertoli S, Ondei P, Bonforte G, Pozzi C, Rossi E, Valsecchi MG, Santoro A. Genovesi S, et al. Among authors: ondei p. J Nephrol. 2017 Aug;30(4):573-581. doi: 10.1007/s40620-016-0364-8. Epub 2016 Nov 11. J Nephrol. 2017. PMID: 27834042 Free article.
25 results